Commodore Capital as of Dec. 31, 2020
Portfolio Holdings for Commodore Capital
Commodore Capital holds 28 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| C4 Therapeutics Com Stk (CCCC) | 8.7 | $16M | 481k | 33.13 | |
| Trillium Therapeutics Com New | 6.8 | $13M | 853k | 14.71 | |
| Constellation Pharmceticls I | 6.6 | $12M | 424k | 28.80 | |
| Five Prime Therapeutics | 4.9 | $9.0M | 532k | 17.01 | |
| Kronos Bio (KRON) | 4.9 | $8.9M | 299k | 29.87 | |
| Iveric Bio | 4.8 | $8.8M | 1.3M | 6.91 | |
| Aclaris Therapeutics (ACRS) | 4.7 | $8.6M | 1.3M | 6.47 | |
| Cogent Biosciences (COGT) | 4.6 | $8.5M | 760k | 11.23 | |
| Cymabay Therapeutics | 4.6 | $8.5M | 1.5M | 5.74 | |
| Pmv Pharmaceuticals (PMVP) | 4.2 | $7.7M | 125k | 61.51 | |
| Syndax Pharmaceuticals (SNDX) | 4.0 | $7.3M | 330k | 22.24 | |
| Xenon Pharmaceuticals (XENE) | 3.9 | $7.2M | 467k | 15.38 | |
| Protagonist Therapeutics (PTGX) | 3.8 | $7.0M | 348k | 20.16 | |
| Mereo Biopharma Group Ads (MREO) | 3.6 | $6.6M | 1.9M | 3.58 | |
| Celldex Therapeutics Com New (CLDX) | 3.4 | $6.2M | 356k | 17.52 | |
| Vistagen Therapeutics Com New | 3.3 | $6.1M | 3.2M | 1.94 | |
| Relmada Therapeutics (RLMD) | 3.1 | $5.7M | 179k | 32.07 | |
| Silverback Therapeutics (SPRY) | 2.4 | $4.5M | 97k | 46.34 | |
| Kura Oncology (KURA) | 2.4 | $4.4M | 134k | 32.66 | |
| Surface Oncology | 2.3 | $4.3M | 468k | 9.24 | |
| Genocea Biosciences Com New (GNCAQ) | 2.3 | $4.3M | 1.8M | 2.42 | |
| Mersana Therapeutics (MRSN) | 2.3 | $4.2M | 159k | 26.61 | |
| Immunovant (IMVT) | 2.1 | $3.9M | 84k | 46.19 | |
| Inventiva Sa Ads (IVA) | 1.8 | $3.4M | 231k | 14.50 | |
| Bcls Acquisition Corp Com Cl A | 1.5 | $2.8M | 250k | 11.14 | |
| Cyclacel Pharmaceuticals | 1.1 | $2.1M | 265k | 7.81 | |
| Millendo Therapeutics | 1.1 | $2.0M | 925k | 2.14 | |
| Lifesci Acquisition Ii Corp | 0.6 | $1.1M | 100k | 10.67 |
